The WHO unveiled a six-month plan to stamp out the ongoing Bundibugyo Ebola outbreak, including scaling a point-of-care molecular testing system. WHO is partnering with Africa CDC, FIND, Unitaid, and local governments, and estimated the plan’s investment need at about $518 million. A central operational piece is expanding use of a point-of-care PCR platform from KH Medical in South Korea, alongside strengthening reference laboratory capacity for diagnostic testing and sequencing-based surveillance. WHO leadership cited case and death counts already exceeding prior Bundibugyo outbreaks at comparable timepoints. The plan adds to the mounting emphasis on faster detection for outbreak control, and positions molecular diagnostics manufacturing and transfer agreements as a near-term bottleneck to solve.